Evidence map›Paper›PMID 40598554›Full record

ArticleJournal of translational medicine2025

Comparative analysis of statistical and deep learning-based multi-omics integration for breast cancer subtype classification.

Mahmoud M Omran, Mohamed Emam, Mariam Gamaleldin, Asmaa M Abushady, Mustafa A Elattar, Mohamed El-Hadidi

Abstract readComparative Study
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. AI-assisted multimodal data integration for precision oncology.Frontiers in artificial intelligence · 2026
    Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahmoud M OmranBioinformatics Group, Center for Informatics Science (CIS), School of Information Technology and Computer Science (ITCS), Nile University, Giza, Egypt.ORCID 0009-0005-9339-4575
Mohamed EmamBioinformatics Group, Center for Informatics Science (CIS), School of Information Technology and Computer Science (ITCS), Nile University, Giza, Egypt.
Mariam GamaleldinSchool of Biotechnology, Nile University, Giza, Egypt.
Asmaa M AbushadySchool of Biotechnology, Nile University, Giza, Egypt.
Mustafa A ElattarSchool of Information Technology and Computer Science, Nile University, Giza, Egypt.
Mohamed El-HadidiBioinformatics Group, Center for Informatics Science (CIS), School of Information Technology and Computer Science (ITCS), Nile University, Giza, Egypt. m.el-hadidi@bham.ac.uk.

Funding

La Caixa 100010434
6 · The paper itself

Abstract

backgroundBreast cancer (BC) is a critical cause of cancer-related death globally. The heterogeneity of BC subtypes poses challenges in understanding molecular mechanisms, early diagnosis, and disease management. Recent studies suggest that integrating multi-omics layers can significantly enhance BC subtype identification. However, evaluating different multi-omics integration methods for BC subtyping remains ambiguous.

methodsIn this study, we conducted a multi-omics integration analysis on 960 BC patient samples, incorporating three omics layers: Host transcriptomics, epigenomics, and shotgun microbiome. We compared two integration approaches the statistical-based approach (MOFA+) and a deep learning-based approach (MOGCN) for this integration. We evaluated both methods using complementary evaluation criteria. First, we assessed the ability of selected features to discriminate between BC subtypes using both linear and nonlinear classification models. Second, we analyzed the biological relevance of the selected features to key BC pathways, focusing on transcriptomics-driven insights.

resultsOur results showed that MOFA+ outperformed MOGCN in feature selection, achieving the highest F1 score (0.75) in the nonlinear classification model, with MOFA+ also identifying 121 relevant pathways compared to 100 from MOGCN. Notably, one of the key pathways Fc gamma R-mediated phagocytosis and the SNARE pathway was implicated, offering insights into immune responses and tumor progression.

conclusionThese findings suggest that MOFA+ is a more effective unsupervised tool for feature selection in BC subtyping. Our study underscores the potential of multi-omics integration to improve BC subtype prediction and provides critical insights for advancing personalized medicine in BC.

Indexed as

Breast NeoplasmsDeep LearningGenomicsFemaleGene Expression ProfilingHumansMultiomicsTranscriptomeBreast cancerF1 scoreFc gamma R-mediated phagocytosisMOFA+MoGCNMulti-omics integrationNetwork analysisPersonalized MedicineSNARE pathway

Identifiers

PMID40598554
PMCPMC12210783

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.